Research ArticleBrain
Progressive Multifocal Leukoencephalopathy in AIDS: Are There Any MR Findings Useful to Patient Management and Predictive of Patient Survival?
M. Judith Donovan Post, Constantin Yiannoutsos, David Simpson, John Booss, David B. Clifford, Bruce Cohen, Justin C. McArthur and Colin D. Hall the AIDS Clinical Trials Group, 243 Team
American Journal of Neuroradiology November 1999, 20 (10) 1896-1906;
M. Judith Donovan Post
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
Constantin Yiannoutsos
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
David Simpson
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
John Booss
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
David B. Clifford
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
Bruce Cohen
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
Justin C. McArthur
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
Colin D. Hall
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).

References
- ↵Hall CD, Dafini U, Simpson D, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 1998;338:1345-1351
- ↵Berger JR, Kaszovitz B, Post MJD, Dickinson G, Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. Ann Intern Med 1987;107:78-87
- Krupp LB, Lipton RB, Swerdlow ML, Leeds NE, Llena J, Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 1985;17:344-349
- Petito CK, Cho ES, Lemann W, Navia BA, Price RW, Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 1986;45:635-646
- ↵Levy RM, Bredesen DE, Rosenblum ML, Neurological manifestations of the acquired immune deficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985;62:475-495
- Berger JR, Moskovitz L, Fischl M, Kelley RE, The neurologic complications of AIDS: frequently the initial manifestation. Neurology 1984;34(Suppl 1):134-135
- ↵Karahalios D, Breit R, Dal Conto MC, Levy RM, Progressive multifocal leukoencephalopathy in patients with HIV infection: lack of impact of early diagnosis by stereotactic brain biopsy. J Acquir Immune Defic Syndr Hum Retrovirol 1992;5:1030-1038
- ↵Sweeney BJ, Miller RF, Harrison MJG, Progressive multifocal leukoencephalopathy. Br J Hosp Med 1993;50:187-192
- Richardson EP, Jr, Progressive multifocal leukoencephalopathy 30 years later. N Engl J Med 1988;318:315-317
- ↵Walker DL, Progressive multifocal leukoencephalopathy. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Demyelinating Diseases: Handbook of Clinical Neurology. Amsterdam: Elsevier; 1985; 47:503–524
- ↵Brooks BR, Walker DL, Progressive multifocal leukoencephalopathy. Neurol Clin 1984;2:299-313
- ↵Portegies P, Algra PR, Hollak CEM, et al. Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1991;337:680-681
- ↵Conway B, Halliday WC, Brunham RC, Human immunodeficiency virus-associated progressive multifocal leukoencephalopathy: apparent response to 3-azido-3 deoxythymidine. Rev Infect Dis 1990;12:479-482
- ↵de Truchis P, Flament-Saillour M, Uetizberea J-A, Hassine D, Clair B, Inefficacy of cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1993;342:622-623
- ↵Nicoli F, Chave B, Peragut JC, Gastaut JL, Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 1992;306:
- Steiger MJ, Tarnesby G, Gable S, McLaughlin J, Schapira AH, Successful outcome of PML with cytarabine and interferon. Ann Neurol 1993;33:407-411
- Berger JR, Pall L, McArthur JG, et al. A pilot study of recombinant alpha 2A interferon in the treatment of AIDS-related progressive multifocal leukoencephalopathy (abstract). Neurology 1992;42(Suppl 3):257
- ↵Tashiro K, Doi S, Moriwaka F, Maruo Y, Nomura M, Progressive multifocal leukoencephalopathy with magnetic resonance imaging verification and therapeutic trials with interferon. J Neurol 1987;234:427-429
- ↵O'Riordan T, Daly PA, Hutchinson M, Shattock AG, Gardner SD, Progressive multifocal leukoencephalopathy: remission with cytarabine. J Infect 1990;20:51-54
- Wolinsky JS, Johnson KP, Rand K, Merrigan TC, Progressive multifocal leukoencephalopathy: clinical pathological correlates and failure of a drug trial in two patients. Trans Am Neurol Assoc 1976;101:81-82
- Garrels K, Kucharczyk W, Wortzman G, Shandling M, Progressive multifocal leukoencephalopathy: clinical and MR response to treatment. AJNR Am J Neuroradiol 1996;17:597-600
- ↵Berger JR, Mucke L, Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 1988;38:1060-1065
- Fong IW, Toma E, the Canadian PML Study Group The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 1995;20:1305-1310
- Hedley-White ET, Smith BP, Tyler HR, Peterson WP, Multifocal leukoencephalopathy with remission and five-year survival. J Neuropathol Exp Neurol 1966;25:107-116
- ↵
- Chappel ET, Guthrie BL, Orenstein J, The role of stereotactic biopsy in the management of HIV-related focal brain lesions. Neurosurgery 1992;30:825-829
- Silver SA, Arthur RR, Erozan YS, Sherman ME, McArthur JC, Uematsu S, Diagnosis of progressive multifocal leukoencephalopathy by stereotactic brain biopsy utilizing immunohistochemistry and the polymerase chain reaction. Acta Cytol 1995;39:35-44
- Levy RM, Rothholtz V, HIV-I-related neurologic disorders: neurosurgical implications in neuroimaging of AIDS II. Neuroimaging Clin N Am 1997;7:527-559
- ↵Weber T, Turner RW, Frye B, et al. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 1994;169:1138-1141
- Moret H, Guichad M, Matherson S, et al. Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol 1993;10:3313
- ↵McGuire D, Barhite S, Hollander H, et al. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 1995;37:395-399
- ↵Fong IW, Britton CB, Luinstra KE, et al. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 1995;33:484-486
- ↵Weber T, Turner RW, Frye S, et al. Progressive multifocal leukoencephalopathy diagnosed by application of JC virus-specific DNA from cerebrospinal fluid. AIDS 1994;8:49-57
- Brouqui P, Bollet C, Delmont J, Bourgeade A, Diagnosis of progressive multifocal leukoencephalopathy by PCR detection of JC virus from CSF. Lancet 1992;339:1182
- ↵Major EO, Ault GS, Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Curr Opin Neurol 1995;8:184-190
- ↵Elliott BC, Aromin I, Flanigan TP, Mileno M, Leukoencephalopathy with combined antiretroviral therapy (abstract). Intervent Conf AIDS 1996;11:222
- Mileno M, Tashima K, Farrar D, et al. Resolution of AIDS-related opportunistic infections with addition of protease inhibitor treatment (abstract). In: Program and Abstracts of the Fourth Conference on Retrovirus and Opportunistic Infections. Washington, DC: January 22–26, 1997
- Huang SS, Skolasky RL, Dal Pan GJ, Royal W, III, McArthur J, Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J Neurovirol 1998;4:324-332
- Clifford DB, the Neurologic AIDS Research Consortium Natural history of progressive multifocal leukoencephalopathy (PML) in AIDS modified by anti-retroviral therapy (abstract). [Neuroscience of HIV infection. Basic Research and Clinical Frontiers, June 3–6, 1998; Chicago, IL] J Neurovirol 1998;7:346
- ↵Wheeler AL, Truwit CL, Kleinschmidt-DeMasters BK, Bryne WR, Hannon RN, Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR images. AJR Am J Roentgenol 1993;161:1049-1051
- Guilleux M-H, Steiner RE, Young IR, MR imaging in progressive multifocal leukoencephalopathy. AJNR Am J Neuroradiol 1986;7:1033-1035
- ↵Mark AS, Atlas SW, Progressive multifocal leukoencephalopathy in patients with AIDS: appearance on MR images. Radiology 1989;173:517-620
- Olsen WL, Longo FM, Mills CM, Norman D, White matter disease in AIDS: findings at MR imaging. Radiology 1988;169:445-448
- Ng S, Tse VC, Rubinstein J, Bradford E, Enzmann DR, Conley FK, Progressive multifocal leukoencephalopathy: unusual MR findings. J Comput Assist Tomogr 1995;19:302-305
- Newton HB, Makley M, Slivka AP, et al. Progressive multifocal leukoencephalopathy presenting as multiple enhancing lesions on MRI: case report and literature review. J Neuroimaging 1995;5:125-128
- Trotot PM, Vazeux R, Yamashita HK, et al. MRI pattern of progressive multifocal leukoencephalopathy (PML) in AIDS. J Neuroradiol 1990;17:233-254
- ↵Whiteman MLH, Post MJD, Berger JR, Tate LG, Bell MD, Limonte LP, Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathogenic correlation. Radiology 1993;187:233-240
- Balakrishnan J, Becker PS, Kumar AJ, Zinreich SJ, McArthur JC, Bryan RN, Acquired immunodeficiency syndrome: correlation of radiologic and pathologic findings in the brain. Radiographics 1990;10:201-215
- Sze G, Brant-Zawadzki MN, Norman D, Newton TH, The neuroradiology of AIDS. Semin Roentgenol 1987;22:42-53
- Sarrazin JL, Soulie D, Derosier C, Lescop J, Schill H, Cordoliani YS, MRI patterns of progressive multifocal leukoencephalopathy. J Neuroradiol 1995;22:172-179
- Lizerbram EK, Hesselink JR, Viral infections. Neuroimaging Clin N Am (Neuroimaging of AIDS I) 1997;7:261-280
- Scatliff JH, Kwock L, Chancellor K, Bouldin TW, Kapoor CC, Castillo M, Postmortem MR imaging of the brains of patients with AIDS. Neuroimaging Clin N Am (Neuroimaging of AIDS I) 1997;7:297-320
- ↵Armand J-D, Dousset V, Viaud B, et al. HIV encephalitis and progressive multifocal leukoencephalopathy: a magnetization transfer study to differentiate pathologic processes. In: Proceedings of the 34th Annual Meeting of the American Society of Neuroradiology, Seattle, 1996. Oak Brook, IL; American Society of Neuroradiology, 1996:27
- ↵Dousset V, Armand J-P, Huot P, Viaud B, Caille J-M, Magnetization transfer imaging in AIDS-related brain diseases. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:447-460
- ↵Thurnher MM, Thurnher SA, Fleischmann D, et al. Comparison of T2-weighted and fluid-attenuated inversion-recovery fast spin-echo MR sequences in intracerebral AIDS-associated disease. AJNR Am J Neuroradiol 1997;18:1601-1609
- Post MJD, Fluid-attenuated inversion-recovery fast spin-echo MR: a clinically useful tool in the evaluation of neurologically symptomatic HIV-positive patients. AJNR Am J Neuroradiol 1997;18:1611-1616
- ↵Chang L, Miller B, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995;197:527
- Chang L, Ernst T, Tornatore C, et al. Metabolic abnormalities in progressive multifocal leukoencephalopathy: a proton magnetic resonance spectroscopy study. Neurology 1997;48:836-845
- Chang L, Ernst T, MR spectroscopy and diffusion-weighted MR imaging in focal brain lesions in AIDS. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:409-426
- Miller JR, Barrett RE, Britton CB, et al. Progressive multifocal leukoencephalopathy in a male homosexual with T cell immunodeficiency. N Engl J Med 1982;307:1436-1438
- Astrom K-E, Mancall EL, Richardson EP, Jr, Progressive multifocal leukoencephalopathy: a hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkin's disease. Brain 1958;81:93-111
- Zu Rhein GM, Chou S-M, Particles resembling papova viruses in human cerebral demyelinating disease. Science 1965;148:1477-1479
- Padgett BL, Walker DL, Zurhein GM, Echroade RJ, Dessel BH, Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1971;1:1251-1260
- Aksamit A, Gendelman H, Orenstein J, Pezeshkpou RG, AIDS-associated progressive multifocal leukoencephalopathy (PML): comparison to non-AIDS PML with in situ hybridization and immunohistochemistry. Neurology 1990;40:1073-1078
- Vazeux R, Cumont M, Girard P, et al. Severe encephalitis resulting from co-infection with HIV and JC virus. Neurology 1990;40:944-948
- Berger JR, Concha M, Progressive multifocal leukoencephalopathy: the evaluation of a disease once considered rare. J Neurovirol 1995;1:5-18
- Budka H, Neuropathology of myelitis, myelopathy and spinal infections in AIDS. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:639-650
- ↵Berger JR, Levy RM, Flomenhoft D, Dobbs M, Predictive factors for prolonged survival in AIDS: associated PML. J Neurovirol 1998;4:342
- Wright D, Schneider A, Berger JR, Central nervous system opportunistic infections. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:513-525
- Henry K, Worley J, Sullivan C, et al. Documented improvement in late stage manifestations of AIDS after starting ritonavir in combination with two reverse transcriptase inhibitors (abstract). Opportun Infec 1997; Jan 22;26:130
- Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1988;338:853-860
- Esiri M, Kennedy P, Viral diseases. In: Adams JH, Duchen LW, eds. Greenfield's Neuropathology. 5th ed. London: Edward Arnsel; 1992:367–370
- ↵Post MJD, Tate LG, Quencer RM, et al. CT, MR and pathology in HIV encephalitis and meningitis. AJNR Am J Neuroradiol 1988;9:469-476
- Post MJD, Berger JR, Duncan R, et al. Asymptomatic and neurologically symptomatic HIV-seropositive subjects: results of long term MR imaging and clinical follow-up. Radiology 1993;188:727-733
- Chrysikopoulos HS, Press GA, Grafe MR, Hesselink JR, Wiley CA, Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation. Radiology 1990;175:185-191
- Post MJD, Sheldon JJ, Hensley GT, et al. Central nervous system disease in acquired immunodeficiency syndrome: prospective correlation using CT, MRI and pathologic studies. Radiology 1986;158:141-148
- Ramsey RG, Geremia GK, CNS complications of AIDS: CT and MR findings. AJR Am J Roentgenol 1988;151:449-454
- Ledoux S, Libman I, Robert F, Just N Progressive multifocal leukoencephalopathy with gray matter involvement. Can J Neurol Sci 1989;16:200-202
- Cunningham ME, Kishore PRS, Rengachary SS, Preskorn S, Progressive multifocal leukoencephalopathy presenting as focal mass lesion in the brain. Surg Neurol 1997;8:448-450
- Carroll BA, Lane B, Norman D, Enzmann D, Diagnosis of progressive multifocal leukoencephalopathy by computed tomography. Radiology 1977;122:137-141
- Tuite M, Keetonen L, Kieburtz K, Handy B, Efficacy of gadolinium in MR brain imaging of HIV-infected patients. AJNR Am J Neuroradiol 1993;14:257-263
- Heinz ER, Drayer BP, Haeinggell CA, Painter MJ, Crumrine P, Computed tomography in white matter disease. Radiology 1979;130:371-378
- ↵Al-Sahi R, Sadler M, Davies E, Nelson MR, Gazzard BG, Progressive multifocal leukoencephalopathy (PML) treatment with cidofovir. Presented at the 12th World AIDS Conference, June 28–July 3, 1998, Geneva, Switzerland
- ↵Acosta A, Regression or stabilization of PML by highly active antiretroviral therapy (HAART) and acyclovir therapy. Presented at the 12th World AIDS Conference, June 28–July 3, 1998, Geneva, Switzerland
- ↵Fichtenbaum CJ, Tantisiviwan W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ, The occurrence of progressive multifocal leukoencephalopathy (PML) in HIV infected persons taking highly active antiretroviral therapy (HAART). Presented at the 12th World AIDS Conference, June 28–July 3, 1998, Geneva Switzerland
In this issue
Advertisement
M. Judith Donovan Post, Constantin Yiannoutsos, David Simpson, John Booss, David B. Clifford, Bruce Cohen, Justin C. McArthur, Colin D. Hall
Progressive Multifocal Leukoencephalopathy in AIDS: Are There Any MR Findings Useful to Patient Management and Predictive of Patient Survival?
American Journal of Neuroradiology Nov 1999, 20 (10) 1896-1906;
0 Responses
Progressive Multifocal Leukoencephalopathy in AIDS: Are There Any MR Findings Useful to Patient Management and Predictive of Patient Survival?
M. Judith Donovan Post, Constantin Yiannoutsos, David Simpson, John Booss, David B. Clifford, Bruce Cohen, Justin C. McArthur, Colin D. Hall
American Journal of Neuroradiology Nov 1999, 20 (10) 1896-1906;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Grey matter abnormality in progressive multifocal leucoencephalopathy
- Progressive multifocal leukoencephalopathy with hypointense halo on MRI
- Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS
- Generalised reversible encephalopathy syndrome: a variant of posterior reversible encephalopathy syndrome (PRES)
- Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients
- CNS-Immune Reconstitution Inflammatory Syndrome in the Setting of HIV Infection, Part 1: Overview and Discussion of Progressive Multifocal Leukoencephalopathy-Immune Reconstitution Inflammatory Syndrome and Cryptococcal-Immune Reconstitution Inflammatory Syndrome
- JC Virus Infection of the Brain
- Use of Diffusion-Weighted Imaging to Evaluate the Initial Response of Progressive Multifocal Leukoencephalopathy to Highly Active Antiretroviral Therapy: Early Experience
- Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature
- Initial and Follow-up MR Imaging Findings in AIDS-Related Progressive Multifocal Leukoencephalopathy Treated with Highly Active Antiretroviral Therapy
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement